...
机译:鳞状细胞癌抗原(SCC)作为非小细胞肺癌血清标记物的重新评估
Division of Respiratory Medicine Institute of Clinical Medicine University of Tsukuba Tsukuba-city Ibaraki 305–8575 Japan;
Division of Respiratory Medicine Institute of Clinical Medicine University of Tsukuba Tsukuba-city Ibaraki 305–8575 Japan;
Division of Respiratory Medicine Institute of Clinical Medicine University of Tsukuba Tsukuba-city Ibaraki 305–8575 Japan;
Division of Respiratory Medicine Institute of Clinical Medicine University of Tsukuba Tsukuba-city Ibaraki 305–8575 Japan;
Division of Respiratory Medicine Institute of Clinical Medicine University of Tsukuba Tsukuba-city Ibaraki 305–8575 Japan;
Non-small cell lung cancer; SCC; CYFRA; Tumor marker; Diagnosis;
机译:放射治疗和放疗后血清血清细胞癌抗原(SCC)和癌胚抗原(CEA)监测子宫子宫颈鳞状细胞癌
机译:术前血清鳞状细胞癌抗原(SCC-AG)对根治手术治疗宫颈鳞状细胞癌患者肿瘤复发的预测值:单制度研究
机译:局部晚期宫颈癌患者血清鳞状细胞癌抗原(SCC-Ag)浓度与复发风险之间的关系评估
机译:腺苷酸环酶相关蛋白1在头部和颈部和非小细胞肺癌的鳞状细胞癌转移中
机译:人类非小细胞肺癌亚型,腺癌和鳞状细胞癌以及小鼠肺上皮细胞系的基因表达分析:在肺肿瘤发生中的意义
机译:子宫颈局部晚期鳞状细胞癌患者血清鳞状细胞癌抗原(SCC-Ag)浓度与复发风险之间关系的评估
机译:组织多肽特异性抗原(TPS)作为妇科恶性肿瘤的肿瘤标志物:与组织多肽抗原(TPA),癌症抗原125(CA125)和鳞状细胞癌相关抗原(SCC)的比较研究